Novo Nordisk
David Rodríguez is a Principal Modelling Scientist at Novo Nordisk with a background in Computational Chemistry, specializing in Structure-Based Drug Design for CNS diseases. Prior to their current role, David held positions at Lundbeck and other research institutions focusing on GPCR families, drug discovery, and bioinformatics. David has a PhD in Molecular Medicine and a strong academic background in biochemistry and molecular research.
This person is not in any teams
Novo Nordisk
377 followers
Novo Nordisk is a global healthcare company with 95 years of innovation and leadership in diabetes care. This heritage has given us experience and capabilities that also enable us to help people defeat obesity, haemophilia, growth disorders and other serious chronic diseases.